# OnCo record nct06395519 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06395519/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06395519", "NCT06395519" ;
  schema:name "A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies"@en ;
  schema:alternateName "ERADIC8"@en ;
  schema:description "A phase 1/2 trial of ETX-19477 in ovarian cancer, prostate cancer, endometrial cancer, colorectal cancer and gastric & gastro-oesophageal junction cancer, run by 858 Therapeutics, Inc., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06395519/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06395519> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2024-05-13" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/gastric/> .